Matthew Voss, MD
Interventional Cardiology · Baltimore, MDNPI 1104830579
Payments from drug & device makers
Across 403 payments — averaging $6444.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1.4M
- Janssen Research & Development, LLC$777K
- Boehringer Ingelheim$339K
- Medtronic$29K
- Boehringer Ingelheim International GmbH$16K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
- plus $4K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $1,425,178 |
| Janssen Research & Development, LLC | 88 | $777,015 |
| Boehringer Ingelheim | 59 | $338,972 |
| Medtronic | 51 | $28,537 |
| Boehringer Ingelheim International GmbH | 107 | $16,374 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $6,677 |
| Edwards Lifesciences | 16 | $2,163 |
| Boston Scientific | 15 | $1,041 |
| Chiesi USA, Inc. | 4 | $266 |
| Abiomed | 3 | $253 |
| Novartis | 12 | $240 |
| Johnson & Johnson | 13 | $127 |
| Shockwave Medical, Inc | 1 | $124 |
| AstraZeneca | 1 | $62 |
| Novo Nordisk | 2 | $41 |
| Cardiva Medical, Inc. | 1 | $27 |
| Teleflex LLC | 1 | $27 |
| Terumo Medical Corporation | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $19 |
| Biotronik Inc. | 1 | $18 |
| Atricure, Inc. | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$2,597,243 in reported general payments places this provider in the 95th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Baltimore
- John WangBaltimore$6.4M
- Aloke FinnBaltimore$1.8M
- Jon ResarBaltimore$592K
- Martin AlbornozBaltimore$403K
- Rani HasanBaltimore$374K
- Anuj GuptaBaltimore$285K
- Ajar KocharBaltimore$162K
- Rohan KalathiyaBaltimore$161K
- Diljon ChahalBaltimore$133K
- Alan JacobsenBaltimore$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.